Conestoga Capital Advisors Sold Mesa Laboratories (MLAB) Due to Inconsistent Performance

By Yahoo! Finance | Aug 16, 2024 at 07:59 AM EST

Conestoga Capital Advisors' Q2 2024 investor letter discusses the moderation in economic indicators, impacting equity markets. Their Micro-Cap Strategy underperformed due to negative stock selection effects. Mesa Laboratories, Inc. was highlighted as a promising investment despite not being among the top holdings.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.